Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2009 Jan;3(1):110-6.
doi: 10.1177/193229680900300112.

An automated discontinuous venous blood sampling system for ex vivo glucose determination in humans

Roland Schaller  1 , Franz Feichtner, Hans Köhler, Manfred Bodenlenz, Johannes Plank, Andrea Wutte, Julia K Mader, Martin Ellmerer, Reinhard Hainisch, Thomas R Pieber, Lukas Schaupp
Affiliations
Clinical Trial

An automated discontinuous venous blood sampling system for ex vivo glucose determination in humans

Roland Schaller et al. J Diabetes Sci Technol. 2009 Jan.

Abstract

Background: Intensive insulin therapy reduces mortality and morbidity in critically ill patients but places great demands on medical staff who must take frequent blood samples for the determination of glucose levels. A cost-effective solution to this resourcing problem could be provided by an effective and reliable automated blood sampling (ABS) system suitable for ex vivo glucose determination.

Method: The primary study aim was to compare the performance of a prototype ABS system with a manual reference system over a 30 h sampling period under controlled conditions in humans. Two venous cannulae were inserted to connect the ABS system and the reference system. Blood samples were taken with both systems at 15, 30, and 60 min intervals and analyzed using a Beckman glucose analyzer. During the study, blood glucose levels were altered through four meal ingestions.

Results: The median Pearson coefficient of correlation between manually and automatically withdrawn blood samples was 0.976 (0.953-0.996). The system error was -3.327 ± 5.546% (-6.03-0.49). Through Clark error grid analysis, 420 data pairs were analyzed, showing that 98.6% of the data were in zone A and 1.4% were in zone B. Insulin titration error grid analysis revealed an acceptable treatment in 100% of cases. A 17.5-fold reduction in the occurrence of blood-withdrawal failures through occluded catheters was moreover achieved by the added implementation in the ABS system of a "keep vein open" saline infusion.

Conclusions: Our study showed that the ABS system described provides a user-friendly, reliable automated means for reproducible and accurate blood sampling from a peripheral vein for blood glucose determination and thus represents a promising alternative to frequent manual blood sampling.

Keywords: automated; blood; ex vivo; glucose; monitoring; sampling.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schematic of the ABS system. A peristaltic pump withdraws and reinfuses peripheral venous blood. Physiological saline solution flushes the system. A Beckman glucose analyzer was used for glucose determination.
Figure 2.
Figure 2.
Illustrative glucose concentration profile for automatically (crosses) and manually (squares) withdrawn reference blood samples obtained during one experiment over 30 h. The subjects received four regular meal ingestions after 6 (dinner), 10 (snack), 21 (breakfast), and 25 hours (lunch) to enable observation of their pre- and postprandial glucose concentration profiles.
Figure 3.
Figure 3.
Error graph for Subjects 1 to 6. Crosses indicate data pairs between the reference method and the ABS system. Bars indicate the standard deviations, and squares display the mean values.
Figure 4.
Figure 4.
System error over time for Subjects 1 to 6 plus the equation of the regression line as a measure of system stability.
Figure 5.
Figure 5.
Clark error grid analysis comparing the data obtained using the ABS system to that of the reference method (Subjects 1–6: crosses), 420 data pairs, Zone A (98.6%, 414), and Zone B (1.4%, 6).
See this image and copyright information in PMC

References

    1. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17(1):107–124. - PubMed
    1. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–1367. - PubMed
    1. Weller C, Linder M, Macaulay A, Ferrari A, Kessler G. Continuous in vivo determination of blood glucose in human subjects. Ann N Y Acad Sci. 1960;87:658–668. - PubMed
    1. Gfrerer RJ, Brunner GA, Trajanoski Z, Schaupp L, Sendlhofer G, Skrabal F, Jobst G, Moser I, Urban G, Pieber TR, Wach P. Novel system for real-time ex vivo lactate monitoring in human whole blood. Biosens Bioelectron. 1998;13(12):1271–1278. - PubMed
    1. Heise HM, Damm U, Bodenlenz M, Kondepati VR, Köhler G, Ellmerer M. Bedside monitoring of subcutaneous interstitial glucose in healthy individuals using microdialysis and infrared spectrometry. J Biomed Opt. 2007;12(2):024004. - PubMed

Publication types